CD8A and neoplasm: PROSTVAC immunotherapy induced polyfunctional PSA-specific T cells, resulted in the infiltration of T cells into tumors, required CD8 T cells for anti-tumor efficacy, and led to antigen spreading which protected mice from re-challenge with tumor cells that lacked PSA expression.